Advertisement

Topics

The Cystic Fibrosis Foundation Company Profile

07:58 EDT 21st April 2018 | BioPortfolio


News Articles [809 Associated News Articles listed on BioPortfolio]

Motif Bio receives award from Cystic Fibrosis Foundation to advance iclaprim

Motif Bio has received an award from the Cystic Fibrosis Foundation, which will fund important in vitro testing to advance the development of iclaprim for the treatment of lung infections in patients ...

Screen for Colorectal Cancer Earlier, More Often in People With Cystic Fibrosis

Adults with cystic fibrosis (CF) should undergo colorectal cancer (CRC) screening with colonoscopy beginning at age 40 and be rescreened every five years, advise consensus recommendations from the Cys...

Vertex Picks 'Impressive' Cystic Fibrosis Drugs To Aim For A Multibillion-Dollar Market

Vertex Pharmaceuticals has picked two cystic fibrosis drugs to test in combination with its existing CF medicine, Kalydeco, as part of two different three-drug combinations aimed at helping as many as...

Vertex Picks ‘Impressive’ Cystic Fibrosis Drugs To Aim For A Multibillion-Dollar Market

Vertex Pharmaceuticals has picked two cystic fibrosis drugs to test in combination with its existing CF medicine, Kalydeco, as part of two different three-drug combinations aimed at helping as many as...

A Dutch Company on the Quest Against Cystic Fibrosis

A young biotech company in the Netherlands is using a different approach to treat cystic fibrosis. ProQR is the result of a personal quest against the disease started by its CEO, Daniel de Boer. Inter...

A Breath of Fresh Air for Biotechs Working on Cystic Fibrosis Therapies?

Researchers from the University of Zurich have determined the structure of a chloride channel, which could be a target for new drugs to treat cystic fibrosis. Researchers at the University of Zurich...

Study offers way to predict onset of lung disease in children with cystic fibrosis

Cystic fibrosis (CF) shortens life by making the lungs prone to repeated bacterial infections and associated inflammation.

Motif Bio Receives Award from Cystic Fibrosis Foundation

NEW YORK, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Motif Bio® plc (AIM:MTFB) (NASDAQ:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that...

PubMed Articles [1382 Associated PubMed Articles listed on BioPortfolio]

Lack of efficacy of Lactobacillus GG in reducing pulmonary exacerbations and hospital admissions in children with cystic fibrosis: A randomised placebo controlled trial.

Intestinal dysbiosis has been described in Cystic Fibrosis (CF) and probiotics have been proposed to restore microbial composition. Aim of the study was to investigate the effects of Lactobacillus rha...

End-of-life practice patterns at U.S. adult cystic fibrosis care centers: A national retrospective chart review.

There are many challenges to providing end-of-life care (EOLC) to people with cystic fibrosis (CF).

Vancomycin Dosing and Monitoring in the Treatment of Cystic Fibrosis: Results of a National Practice Survey.

Vancomycin is commonly used in patients with cystic fibrosis (CF) to treat acute pulmonary exacerbations, but few guidelines exist to help dose and monitor patients. The objective of this study was to...

Audiometric assessment of pediatric patients with cystic fibrosis.

The purpose of this study was to evaluate hearing impairment in pediatric patients with cystic fibrosis (CF).

The association between Staphylococcus aureus and subsequent bronchiectasis in children with cystic fibrosis.

Staphylococcus aureus (S. aureus) may be related to more rapid progression of cystic fibrosis (CF) lung disease.

Clinical Trials [1464 Associated Clinical Trials listed on BioPortfolio]

Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients

This is a prospective, longitudinal, 5-year study that will enroll participants from the existing Cystic Fibrosis Foundation (CFF) patient registry. Each enrolled participant will provide ...

Miglustat / OGT 918 in the Treatment of Cystic Fibrosis

Cystic fibrosis is a genetic disease caused by mutation of the cystic fibrosis transmembrane conductance regulator (CFTR). The purpose of the study is to investigate the effects of miglust...

Exercise-Induced Bronchospasm in Cystic Fibrosis

Exercise is an important clinical feature in cystic fibrosis. Better exercise capacity has been associated with better patient outcomes and quality of life. Exercise-induced bronchospasm...

Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis

OBJECTIVES: Evaluate the efficacy and safety of lipid-mediated transfer of the cystic fibrosis transmembrane conductance regulator gene to nasal epithelium in patients with cystic f...

Study of Uridine Triphosphate (UTP) as an Aerosol Spray for Cystic Fibrosis

OBJECTIVES: I. Determine the stability of uridine triphosphate (UTP) and examine the metabolism of exogenous nucleotides on airway epithelial surfaces in patients with cystic fibrosis. ...

Companies [1417 Associated Companies listed on BioPortfolio]

Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. The Foundation funds more CF research than any other organization and nearly every CF drug available ...

Cystic Fibrosis Foundation, Northern Ohio Chapter

The Northern Ohio Chapter of the Cystic Fibrosis Foundation works to help develop a means to control and cure cystic fibrosis and to improve the lives of those with the dis...

Cystic Fibrosis Trust

•        Cystic fibrosis is chronically misunderstood, kills thousands worldwide and is carried unknowingly in the genes of millions. It's often invisible...

New Lung Associates

New Lung Associates is a pulmonary group of physicians leading the Lung Transplant Program and the Adult Cystic Fibrosis Program at Tampa General Hospital, a 988-bed acute care ho...

The Cystic Fibrosis Foundation

More Information about "The Cystic Fibrosis Foundation" on BioPortfolio

We have published hundreds of The Cystic Fibrosis Foundation news stories on BioPortfolio along with dozens of The Cystic Fibrosis Foundation Clinical Trials and PubMed Articles about The Cystic Fibrosis Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Cystic Fibrosis Foundation Companies in our database. You can also find out about relevant The Cystic Fibrosis Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record